Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ANSM
Description:
France’s public agency responsible for evaluating and regulating the safety of medicines and other health products.
Related topics:
Pharmacovigilance and Adverse Drug Reactions (17%),
Healthcare Regulation (13%),
Pharmaceutical Economics and Policy (8%)
Wikidata ID:
wiki/Q392516
OpenAlex ID:
keywords/ansm
Agence nationale de sécurité du médicament et des produits de santé
2013
·
Sébastien Colson
·
Cahiers de la Puéricultrice
·
392
Veille et sécurité sanitaire des toxiques – implication des agences sanitaires – Agence nationale de sécurité du médicament et des produits de santé (ANSM)
2015
·
P. Maison
, C. Picot
, et al.
·
Annales de Toxicologie Analytique
·
62
The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study
2020
·
Amine Benhabib
, Saïd Ioughlissen
, et al.
·
BMJ Open
·
61
PDF
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
2021
·
Clémence Lacroix
, Francesco Salvo
, et al.
·
Therapies
·
28
PDF
Du médicament psychoactif à l’addictovigilance dans le Code de la santé publique en France (1990–2017)
2018
·
Marie Baumevieille
, Joëlle Perri-Plandé
, et al.
·
Therapies
·
28
PDF
French hip resurfacing registry: A study of 1650 cases
2021
·
Julien Girard
, Jean Alain Epinette
, et al.
·
Orthopaedics & Traumatology Surgery & Research
·
23
France Grants an Approval to Baclofen for Alcohol Dependence
2019
·
Benjamin Rolland
, Nicolas Simon
, et al.
·
Alcohol and Alcoholism
·
23
National reflection on organs-on-chip for drug development: New regulatory challenges
2023
·
Sonia Gomes Teixeira
, Paul Houeto
, et al.
·
Toxicology Letters
·
22
Faecal microbiota transplantation: A sui generis biological drug, not a tissue
2014
·
F. Megerlin
, E. Fouassier
, et al.
·
Annales Pharmaceutiques Françaises
·
19
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience
2023
·
Laëtitia Belgodère
, Joseph Emmerich
, et al.
·
Frontiers in Public Health
·
18
PDF
12/12 L’Agence nationale de sécurité du médicament et des produits de santé
2014
·
Carine Lim
·
Soins Cadres
·
18
Materials vigilance and traceability
2016
·
P. Tracol
·
Orthopaedics & Traumatology Surgery & Research
·
15
PDF
The French pharmacovigilance surveys: A French distinctiveness, a real input
2020
·
Malak Abou Taam
, Baptiste Jacquot
, et al.
·
Therapies
·
13
PDF
Regulatory aspects of prospective and retrospective clinical research in France in 2018
2019
·
P. Gorphe
, C. Jannin
·
European Annals of Otorhinolaryngology Head and Neck Diseases
·
12
Intérêt de la mise à disposition de la naloxone auprès des usagers de drogues pour le traitement d’urgence de surdosage d’opioïdes
2018
·
Elisabeth Frauger
, Farid Kheloufi
, et al.
·
Therapies
·
12
French drug trial had three major failings, says initial report
2016
·
Nigel Hawkes
·
BMJ
·
12
France launches new drug regulatory agency
2012
·
Martine Lochouarn
·
The Lancet
·
12
PDF
New law introduces tougher rules on drug regulation in France
2011
·
P. Benkimoun
·
BMJ
·
12
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
2023
·
Annie Pierre Jonville-Bera
, Sophie Gautier
, et al.
·
Therapies
·
11
PDF
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
2021
·
Stéphane Vignot
, Pascale Daynes
, et al.
·
Frontiers in Pharmacology
·
11
PDF
Pharmacovigilance française : missions, organisation et perspectives
2016
·
Thierry Vial
·
Therapies
·
11
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
2022
·
Antoine Pariente
, Joëlle Micallef
, et al.
·
Therapies
·
10
PDF
Création de l’Agence nationale de sécurité sanitaire du médicament et des produits de santé
2012
·
Élisa Derrien
·
Actualités Pharmaceutiques
·
9
Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
2023
·
Laëtitia Belgodère
, Dominique Pougheon Bertrand
, et al.
·
BMJ Global Health
·
8
PDF
Current legislation on tattooing in France
2020
·
Nicolas Kluger
, Christiane Bruel
, et al.
·
La Presse Médicale
·
8
PDF
Show more works
View as search
Works count:
316
Citation count:
1,044
Year
Topic
Type